Top 50 Medical Startup Investors in Finland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Finnvera Venture Capital
VC Fund
|
7 | Finland, United States, Switzerland | Seed, Series A | Software, Health Care, Information Technology | $250k–$22M |
|
Business Finland
VC Fund
|
7 | Finland, United States, United Kingdom | Seed, Grant, Debt Financing | Software, SaaS, Biotechnology | $48k–$11M |
|
Voima Ventures
VC Fund
|
6 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $439k–$18M |
|
Lifeline Ventures
VC Fund
|
5 | Finland, United States, United Kingdom | Seed, Series A | Software, Health Care, E-Commerce | $547k–$20M |
|
Maki.vc
VC Fund
|
4 | Finland, Norway, Denmark | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $900k–$37M |
|
Icebreaker.vc
VC Fund
|
3 | Finland, Estonia, Sweden | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $106k–$25M |
|
Reaktor Ventures
VC Fund
|
3 | Finland, Germany, United States | Seed, Pre-Seed, Series A | Internet, Software, E-Commerce | $137k–$6.6M |
|
Innovestor
VC Fund
|
3 | Finland, Denmark, Sweden | Seed, Pre-Seed | Software, Health Care, Information Technology | $163k–$4.1M |
|
Butterfly Ventures
VC Fund
|
3 | Finland, Sweden, Norway | Seed, Pre-Seed | Health Care, Software, Information Technology | $110k–$4.4M |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
Vesalius Biocapital Partners
VC Fund
|
2 | Belgium, Germany, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | |
|
Springvest
VC Fund
|
2 | Finland | Series A, Seed | Biotechnology, Health Care, Energy | $3.6M–$53M |
|
Samsung Venture Investment
VC Fund
|
2 | South Korea, United States, India | Series A, Series B, Seed | Information Technology, Software, Health Care | $45k–$25M |
|
Inventure
VC Fund
|
2 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$23M |
|
Jyri Engestrom
Angel
|
2 | United States, Finland, Spain | Seed, Pre-Seed, Series A | Software, Apps, Internet | $600k–$20M |
|
Anssi Vanjoki
Angel
|
2 | Finland | Angel, Series A | Medical, Hardware, Health Care | |
|
Asko Schrey
Angel
|
2 | Finland | Seed, Angel | Software, Artificial Intelligence, FinTech | |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Metsola Ventures
VC Fund
|
2 | Finland | Series A | Medical, mHealth, Health Care | $2.2M–$4.8M |
|
Cor Group
VC Fund
|
1 | Finland | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | |
|
Torrey Pines Investment
VC Fund
|
1 | United States, Russian Federation, The Netherlands | Seed, Pre-Seed | Biotechnology, Health Care, Pharmaceutical | $3M–$3.1M |
|
J12
VC Fund
|
1 | Sweden, Germany, Norway | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $420k–$64M |
|
Ali Omar
Angel
|
1 | Finland, United States, Estonia | Seed, Pre-Seed, Angel | Software, SaaS, Artificial Intelligence | $53k–$2.1M |
|
Korpun Siemen
VC Fund
|
1 | Finland | Seed, Angel | Software, Marketing, Information Technology | $480k–$1.3M |
|
SHS Capital
VC Fund
|
1 | Germany, Switzerland, France | Series C, Series A | Health Care, Medical Device, Medical | $4.3M–$31M |
|
Sandwater
VC Fund
|
1 | Norway, Germany, France | Series A, Seed | AgTech, Medical, Agriculture | $7.7M–$36M |
|
Noaber
VC Fund
|
1 | The Netherlands, Israel, Sweden | Seed, Series A | Health Care, Medical, Fitness | $1.3M–$20M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
1 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $909k–$33M |
|
Nuard Ventures
VC Fund
|
1 | Finland, Germany, United States | Seed | IaaS, Video, Fashion | $339k–$680k |
|
Ascend Capital Partners
VC Fund
|
1 | Finland, Israel, Austria | Series A, Seed | Health Care, Medical Device, Software | $1.5M–$12M |
|
Athensmed
VC Fund
|
1 | Finland | Seed, Series A | Health Care, Medical, mHealth | $1.1M–$1.3M |
|
DigiTx Partners
VC Fund
|
1 | United States, Canada, Finland | Series A, Seed, Series B | Health Care, Artificial Intelligence, Medical | $2.7M–$43M |
|
XR Invest
VC Fund
|
1 | Finland, United States | Series A, Series C | Medical Device, Sensor, Medical | |
|
Metaplanet
VC Fund
|
1 | United States, United Kingdom, Estonia | Seed, Series A, Series B | Artificial Intelligence, Software, Health Care | $2.4M–$62M |
|
Tesi
VC Fund
|
1 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Health Care | $2.2M–$41M |
|
Gaingels
VC Fund
|
1 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.5M–$100M |
|
Cascara Ventures
VC Fund
|
1 | Germany, Finland, The Netherlands | Series A, Seed, Series B | Medical, Health Care, Biotechnology | |
|
Capricorn Partners
VC Fund
|
1 | Belgium, United States, The Netherlands | Series A, Series B | Biotechnology, Health Care, Software | $3.3M–$42M |
|
Jukka Tapaninen
Angel
|
1 | Finland | Seed | Medical, Software, Education | |
|
Sunstone Life Science Ventures
VC Fund
|
1 | Denmark, Sweden, Switzerland | Series B, Series A | Biotechnology, Health Care, Medical | |
|
Visionplus
VC Fund
|
1 | Finland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Internet | $77k–$14M |
|
Nordea
VC Fund
|
1 | Finland, Sweden, Norway | Debt Financing, Seed | FinTech, Financial Services, Banking | |
|
Inveni Capital
VC Fund
|
1 | Finland, United Kingdom | Medical, Health Care, Biotechnology | ||
|
MVM Life Science Partners
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series B, Series C | Health Care, Biotechnology, Medical | |
|
Nordic Science Investments
VC Fund
|
1 | Finland | Seed | Apps, Food Processing, Food and Beverage | |
|
M Ventures
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Unifund
VC Fund
|
1 | Finland | Software, Collaboration, Management Consulting | ||
|
Marten Mickos
Angel
|
1 | Finland, United States, Sweden | Seed, Series A, Convertible Note | Software, Enterprise Software, Internet | $550k–$4.5M |
|
Hadean Ventures
VC Fund
|
1 | Norway, Sweden, Germany | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
Petri Pöyhönen
Angel
|
1 | Finland | Series A | Medical, Biotechnology, Medical Device | |
| Access all 87 investors in Finland Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 92
- Round size: Seed $250k–$1.5M; Series A $1.7M–$22M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Grant, Debt Financing
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 181
- Round size: Seed $127k–$4.2M; Grant $48k–$11M; Debt Financing $212k–$4.9M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- SSAB —
- Valio — We are Valio Group: the most innovative dairy and food company in the world.
- Jaakko.com — Reinventing the housing market with no agents, more homes, and less fees.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.5M; Pre-Seed $439k–$2.1M; Series A $3.8M–$18M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
- Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 178
- Round size: Seed $547k–$5.4M; Series A $2.7M–$20M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $171M in 2023
Portfolio highlights
- ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
- Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
- Everywear Games — Metacore is a wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s games are consistently on top ofglobal charts.
We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Norway, Denmark
Investor stats
- Total investments: 92
- Round size: Seed $900k–$8M; Pre-Seed $1.1M–$2.7M; Series A $3.3M–$37M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Yaak Technologies ApS — Safety in urban self-driving is currently an afterthought. At Yaak, we distill safety from driving experts for the next generation of human and autonomous driving.
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Estonia, Sweden
Investor stats
- Total investments: 121
- Round size: Seed $384k–$5.2M; Pre-Seed $106k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 55% lead, 45% follow
- Last fund: May invest from a new fund soon — raised $22M in 2021
Portfolio highlights
- Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 54
- Round size: Seed $137k–$2M; Pre-Seed $159k–$1.8M; Series A $1.7M–$6.6M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
- Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Denmark, Sweden
Investor stats
- Total investments: 74
- Round size: Seed $507k–$4.1M; Pre-Seed $163k–$2M
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 86
- Round size: Seed $219k–$2.1M; Pre-Seed $110k–$4.4M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- 10Lines — Explore cutting-edge pavement marking robots for faster, autonomous striping and significant CO2 reduction. Contact us now!
- CooliBlade — Superior power electronics cooling solutions for applications like solar and wind energy, energy storage, EV charging and telecommunications.
- Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 271
- Lead/follow: no public data
Portfolio highlights
- Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
- Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.
- Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: Belgium, Germany, The Netherlands
Investor stats
- Total investments: 55
- Lead/follow: no public data
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 20
- Round size: Series A $3.6M–$53M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, India
Investor stats
- Total investments: 121
- Round size: Seed $45k–$3.2M; Series A $1.6M–$25M; Series B $3M–$23M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- N.THING — Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by combining IoT technology and data. It developed the world’s first modular vertical farm ‘CUBE’ which is easy to expand. N.THING CUBE is a modularized farm with massproductivity where a dedicated OS provides the most optimized environment for each crop so as to create maximized efficiency. N.THING is the world’s first smart farming company that won the iF Design Award, Architecture in 2020. Also, it is a winner of Best of Innovation at the CES 2020 for its excellence in technology, which is the first ever in the agricultural field. N.THING is planning to expand its business on a large scale this year after it successfully completes the PoC process in the U.A.E. Our North American branch office located in New York. N.THING hopes to connect people to nature, things to things, people to things, and people to people through IoT technologies by creating Number of Things out of Nothing. .CUBE : CUBE is internet connected modular container vertical farm. It's an ultimate indoor farm which contains LED technology, real time monitoring system through IoT sensors, collected cultivation data, and upgradable software. We deliver the farm of the desired container form to the desired place.SQUARE : SQUARE is modular hydroponic kit. SQUARE can connect each module and share water. Users can connect as many as they want, grow greens and herbs, and make food great themselves. Each Square consists of four Pickcells, which contains special nutrient-rich sponge. With special sponge and hydroponic, it gives the most simple and effective gardening experience.Planty : Planty is the first Internet-connected social pot in the world. Planty gives pleasure to grow plants with your family, friend, and colleague. Planty enables the user to monitor the environmental information on temperature, soil moisture, and ambient light around plants and give water to plants any me or anywhere.Life : Life is a smart gardening journal aimed at the gardening sector. Plant lovers and gardeners are able to record their gardening activities and information and share them through Social Media. The user can easily insert weather data, location data, gardening activities, and plants’ events. Moreover, all the gardening data can be shared through social media.Sikmulsung: Sikmulsung is our show room to explore 'freshness' of our product and service. It is a place for everyone seeking for 'freshness' in visual, in texture, in taste, in flavor or even in atmosphere with, N.THING's in-store farm, exclusively made for Sikmulsung, special F&B's and our end products.
- MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
- Aim Intelligence — Leading AI Security & Safety Solutions Provider - Specializing in AI Risk Detection, Mitigation, and Elimination through Advanced Red Teaming and Defensive Systems | Leading provider of AI Security, Safety, and Compliance solutions
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 164
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$23M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Omocom — Omocom offers safe, simple and secure insurance for all kind of renting, sharing and re-using, digitally, automated and integrated into the sales flow of the platform
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Jyri Engeström is an Investor and Partner of Yes VC. He attended Lancaster University
Show more...Investment focus
- Industry: Software, Apps, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Finland, Spain
Investor stats
- Total investments: 30
- Round size: Seed $600k–$4.7M; Series A $2.8M–$20M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
- Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
- Gyroscope Innovations — Gyroscope Innovations is a new OS for the human body. It was started by Anand Sharma in 2014 as a personal project called April Zero.
As Executive Vice President and General Manager of Multimedia, Nokia, Anssi Vanjoki heads a business group that is responsible for developing Nokia Nseries multimedia computers and associated experiences and services. This fast growing segment of consumer electronics will shape our lives in a fundamental way. A highly respected brand authoritywith over 25 years of marketing experience, Anssi has been a driving force in Nokia's efforts to address the mobile markets. His work has focused on developing Nokia's brand durability, loyalty and continuity, while, at the same time, advancing Nokia's vision of a mobile world. Anssi joined Nokia in 1991 and was named Vice President, Sales, Nokia Mobile Phones, before his promotion in 1994 to Senior Vice President, Nokia Mobile Phones Europe and Africa. In 1998 he was made Executive Vice President, Nokia Mobile Phones Europe and Africa and became a member of the Group Executive Board of Nokia. In addition, in 1999, Anssi took responsibility for Nokia's Digital Convergence Unit and, in 2002, also headed up the Business Unit Management. He was appointed to his present position on January 1st 2004. Prior to joining Nokia, Anssi held a variety of management positions at 3M Corporation. Anssi is the Chairman of the Board of Amer Group, and was a member of the Governing Committee of the European Foundation for Quality Management 2001 - 2003. He is a Knight, 1st Class, of the Order of the White Rose of Finland. Anssi holds a master's degree in economics from the Helsinki School of Economics and Business Administration.
Show more...Investment focus
- Industry: Medical, Hardware, Health Care
- Stage:Angel, Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Asko Schrey
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Zefort — Zefort is a powerful contract management software. Sign, store, share contracts and easily with your team. Set reminders and use a powerful search.
- ContractZen Governance Suite — ContractZen corporate governance software is ideal for contract management, board meeting management, entity management, e-signature & virtual data room (VDR).
- ReceiptHero — Say goodbye to paper receipts. Cut operational costs, reduce waste and deliver a better in-store experience for customers.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 26
- Round size: Series A $1.3M–$73M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Metsola Ventures
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Series A $2.2M–$4.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from internationalpharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A.We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: United States, Russian Federation, The Netherlands
Investor stats
- Total investments: 32
- Round size: Seed $3M–$3.1M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $60M in 2017
Portfolio highlights
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
- BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
- MAIR PHARMACEUTICALS — Mair Pharmaceutical creates innovative processes and produces well-known unique substances for pharmaceutical and biopharmaceutical firms worldwide.
J12 is a thesis-driven venture capital firm partnering early with technical founders across Europe to build category-defining data and AI companies across infrastructure, tooling, and domain-specific applications
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Sweden, Germany, Norway
Investor stats
- Total investments: 56
- Round size: Seed $1.5M–$7.7M; Pre-Seed $420k–$4.4M; Series A $7M–$64M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Treyd — Working capital for fast growing brands. Order Now, Pay Suppliers Later
- Dema.ai — First-of-its-kind AI decision platform for e-commerce
- MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: Finland, United States, Estonia
Investor stats
- Total investments: 62
- Round size: Seed $263k–$2.1M; Angel $53k–$1.6M; Pre-Seed $163k–$724k
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- MÖ Foods — MÖ Kaurajogu is domestic, completely herbal and above all delicious. All our products are manufactured in Central Ostrobothnia, Lohtaja.
- React & Share — High volume, high quality feedback directly from your customers. React & Share helps digital comms teams improve their websites and satisfy their customers.
- Plain Complex — VUOROX IS AN AI-POWERED ROSTER SCHEDULING APP FOR HEALTHCARE
Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.
Show more...Investment focus
- Industry: Software, Marketing, Information Technology
- Stage:Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 10
- Round size: Seed $480k–$1.3M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
- Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
- Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
SHS is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics, and Digital Health sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series C, Series A
- Geography: Germany, Switzerland, France
Investor stats
- Total investments: 42
- Round size: Series A $4.3M–$31M; Series C $6.6M–$14M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
- Simulands — Human grade cardiovascular simulators
- ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.
Show more...Investment focus
- Industry: AgTech, Medical, Agriculture
- Stage:Series A, Seed
- Geography: Norway, Germany, France
Investor stats
- Total investments: 17
- Round size: Series A $7.7M–$36M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Mantle8 — Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A
- Geography: The Netherlands, Israel, Sweden
Investor stats
- Total investments: 19
- Round size: Seed $1.3M–$6.3M; Series A $3M–$20M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 542
- Round size: Seed $909k–$6.5M; Series A $3M–$33M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Sdui — Sdui is the solution for mobile communication in schools. With amazingly easy features for messaging, timetables and a wide range of third party integrations, the app digitizes processes and reduces administrative effort. Within two years, Sdui has reached hundreds of institutions and grown a serious reputation in the educational market.
- envelio — We are driving forward the energy transition with our smart grid solutions for grid operators. Get information now and plan smart!
- Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
Nuard Ventures invests in innovative early stage companies.
Show more...Investment focus
- Industry: IaaS, Video, Fashion
- Stage:Seed
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 6
- Round size: Seed $339k–$680k
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- WARD — WARD is a fantasy sport game, where fans can watch their favourite eSports matches and predict what will happen in real time.WARD is a startup out of Berlin which has created a “pick and predict” real-time prediction smartphone game, where players can win real prizes. People love to watch e-sports. We believe on these occasions they still want tobe able to participate.However, until now no product has offered anything other than the ability to watch. There’s been no way for fans to spectate, participate, analyse and predict the outcomes of their favourite games.
- MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
- Polka Dot Studio — Kalian Bisa Memasang Taruhan Online Dengan Sangat Mudah Dan Nyaman Di Situs DEWAHOKI Yang Sudah Resmi Di Indonesia
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Series A, Seed
- Geography: Finland, Israel, Austria
Investor stats
- Total investments: 18
- Round size: Seed $1.5M–$9.3M; Series A $2.2M–$12M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- DriveU.auto — Transform existing terminal tractors into autonomous vehicles. Fast ROI. Continuous operation in mixed traffic.
- Pionix — open source software as a service for charging stations / e-mobility
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Athensmed Oy
Show more...Investment focus
- Industry: Health Care, Medical, mHealth
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Seed $1.1M–$1.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
At DigiTx Partners,we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcareecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Finland
Investor stats
- Total investments: 29
- Round size: Seed $2.7M–$6M; Series A $4M–$25M; Series B $6M–$43M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $75M in 2018
Portfolio highlights
- StrokeDx — Boldly transforming how strokes are diagnosed with innovative, rapid, and portable devices. StrokeDx develops next-generation point-of-care stroke diagnostic technologies to reduce the time to treatment in acute stroke care and triage.
- Cerula Care — Cerula Care specializes in behavioral health services for people with chronic conditions.
- Neon Health — Neon accelerates patient access to critical care by jumping through all the hoops to onboard and adhere to life-saving drugs, treatments.
XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.
Show more...Investment focus
- Industry: Medical Device, Sensor, Medical
- Stage:Series A, Series C
- Geography: Finland, United States
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Estonia
Investor stats
- Total investments: 98
- Round size: Seed $2.4M–$12M; Series A $5.9M–$40M; Series B $23M–$62M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Vok Bikes — We build heavy-duty cargo bikes and rent them out to on-demand delivery companies and their couriers — no surprises, no extra fees. Currently active in Tallinn and Vilnius and expanding to London and Berlin Q4 2021.
- Zama — Secure data privacy of your application with the Zama Concrete framework and its fully homomorphic encryption library
- Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 142
- Round size: Series A $2.2M–$41M; Series B $3.1M–$35M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
- Wirepas — Wirepas offers a standards-based, ultra-reliable mesh connectivity for infrastructure-grade IoT. Proven in millions of devices worldwide.
- MaaS Global — Whim combines all the transportation you need: Public transport, shared cars, bikes, e-scooters, taxis, and more! One app to plan, book, and pay.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 687
- Round size: Seed $1.5M–$8M; Series A $6M–$43M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Epirus — Epirus is a high-growth technology company that develops cutting-edge directed energy systems and power management solutions to transform multiple industries.
- Operant — Own OperantAi.com today. Secure checkout and guided transfer support. No hidden fees.
- Quadient Accounts Receivable by YayPay — YayPay accounts receivable automation software helps businesses collect faster, forecast cash flow accurately, and improve payment process. Automate your AR
96 Normal 0 false false false EN-GB X-NONE X-NONE
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Germany, Finland, The Netherlands
Investor stats
- Total investments: 11
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
- ATRO Medical — ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype.
- microDimensions — microDimensions provides digital pathology software and services: image analysis, 3D histology reconstruction, protein multiplexing, stereology, image registration.
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 112
- Round size: Series A $3.3M–$18M; Series B $5.3M–$42M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Neotiv — Enabling cognitive health
- Thryve — Thryve’s SDK brings everything you need to access fragmented wearable, medical devices, and health data silos with a single integration. We unify your users’ data from smartwatches, blood glucose meters, and many other sources that unlock a continuous stream of harmonized health information for your care. We support popular data sources like AppleHealth, Google Fit, Huawei Health, Samsung Health, and many more.
- VOID Technologies — VOID Technologies is a groundbreaking materials science company spun out of Kimberly-Clark to commercialise the VO+ technology. Our business model is based on supplying VO+ additive masterbatches to film manufacturers.
Jukka Tapaninen is an experienced IT business executive and a board member at Fimmic. Jukka also holds board positions at weVision, Addoro Ab, Findity and MeshWorks Wireless Oy.Jukka has a strong background in the IT industry on managing companies and business units globally. His leadership experience, from large companies like SAP and HP, aswell as from strong midsize companies has given him industry knowledge and excellent network within the strategic ecosystem and major customers. Jukka has experience in working in the United States, Singapore and multiple locations in Europe that have given him a good understanding on how business is done in different parts of the world.Jukka holds a M.Sc. degree from the Helsinki School of Economics.
Show more...Investment focus
- Industry: Medical, Software, Education
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 54
- Lead/follow: no public data
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $77k–$1.3M; Series A $2M–$14M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Pebble — Pebble is a electric vehicle manufacturing startup.
- Transfluent — Professional translations for all business needs. Fast. Easy.
- BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
Nordea Bank is Denmark's second-largest bank and counts every fourth Dane among its customers. Through their nationwide network of some 340 branch offices and a broad range of self-service facilities, they are able to offer you a full scale of financial products and services, including Netbank, Online Investment, telephone banking and cashdispensers.
Show more...Investment focus
- Industry: FinTech, Financial Services, Banking
- Stage:Debt Financing, Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Tibber — Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs.
- Statzon — Make data-driven plans & faster decisions with a simple access to +1M datasets & market reports about 8,000 topics from +200 trusted data providers.
- Get It Done Now — GIDN is a Nigerian Fintech Company targeting medium and low income population for Loans and Financial products. GIDN has in addition a cashless, mobile based community marketplace, with more than 5k members, and aims to regulate the informal economy and facilitate the purchase of Services and Digital Products.
Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Finland, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
- Onbone — Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain.
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 70
- Lead/follow: no public data
Portfolio highlights
- Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
- Gynesonics — Gynesonics is a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions. Gynesonics serves customers worldwide. It was founded in 2005 and is headquartered in Redwood City, California.
- Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Apps, Food Processing, Food and Beverage
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- AIATELLA — Automating medical image analysis
- Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 163
- Round size: Seed $2.4M–$21M; Series A $5.2M–$45M; Series B $15M–$100M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- CellFE — We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
- UNISERS — Developing solutions for Universal Contamination Analysis. Working with cutting edge technologies to revolutionize contamination control.
- Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.
Show more...Investment focus
- Industry: Software, Collaboration, Management Consulting
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
- PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
Marten Mickos is the CEO of HackerOne, Inc. the leading vulnerability coordination and bug bounty platform. Previously Marten was the CEO of Eucalyptus Systems, acquired by Hewlett-Packard where he served as head of the cloud business. As the CEO of MySQL AB from 2001 to 2008, Marten grew that company from a garage start-up to the second largestopen source company in the world. Marten holds a M.Sc. in technical physics from Helsinki University of Technology in his native Finland.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 15
- Round size: Seed $550k–$4.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Queer Spaces — Spaces is a group chat platform for building queer communities, and the first app to serve the entirety of the LGBTQ+ spectrum.
- Tangled — The next-generation social coding platform.
- Pandatron — With clients like SAP, Universal Pictures & Skanska, Pandatron is a startup that supports change management. We do it by scaling AI-driven coaching 1-on-1s to every employee, which also allows us to measure change.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Germany
Investor stats
- Total investments: 27
- Round size: Series A $4.3M–$79M; Series B $28M–$68M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Emergence Therapeutics — Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 – an important target for a broad range of cancers which has been clinically validated as anADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Petri Pöyhönen
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Medical Investor funding in Finland at a glance
Stats across 80 deals from 87 investors.
Access all 87 investors in Finland Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 87 investors investing in Finland Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!